We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
In response to the recent identification of two Lassa fever cases in Togo, the Ministry of Health is carrying out an investigation into the outbreak with support from WHO and CDC. Activities include the review of cases at the affected health facility in Togo. Community disease awareness campaigns are underway.
Contact tracing and follow-up are being performed. As of 18 March 2016, contacts were being monitored in Togo (13), Germany (52) and United States (1).
(Via WHO Disease Outbreak News - accessed 29/03/16)
Lassa fever is a low risk for most travellers unless living in poor sanitary conditions with overcrowding in rural areas where the host is usually found. Lassa fever is a zoonotic viral disease transmitted via the excreta of an infected Mastomys rat. Healthcare workers are at risk if good infection control and barrier nursing methods are not maintained.
Travellers returning from affected areas who develop symptoms of fever, malaise, headache, sore throat, muscle pain, chest pain, nausea, vomiting, diarrhoea, and abdominal pain should seek medical advice.
